Marcio Souza
Chief Executive Officer bij PRAXIS PRECISION MEDICINES, INC.
Vermogen: 926 040 $ op 31-03-2024
Profiel
Marcio Souza is the President, Chief Executive Officer & Director at Praxis Precision Medicines, Inc. He previously worked as the Executive Director-Marketing at NPS Pharmaceuticals, Inc. and as the Chief Operating Officer at PTC Therapeutics, Inc. He also served as an Independent Director at Clearpoint Neuro, Inc. and Spyre Therapeutics, Inc. Mr. Souza holds an MBA from Fundação Dom Cabral and an undergraduate degree from the University of Sao Paulo.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
12-02-2024 | 15 176 ( 0.11% ) | 926 040 $ | 31-03-2024 |
Actieve functies van Marcio Souza
Bedrijven | Functie | Begin |
---|---|---|
PRAXIS PRECISION MEDICINES, INC. | Chief Executive Officer | 01-04-2020 |
Eerdere bekende functies van Marcio Souza
Bedrijven | Functie | Einde |
---|---|---|
SPYRE THERAPEUTICS, INC. | Director/Board Member | 22-06-2023 |
CLEARPOINT NEURO, INC. | Director/Board Member | 27-04-2020 |
PTC THERAPEUTICS, INC. | Chief Operating Officer | 01-04-2020 |
NPS PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 01-07-2014 |
Opleiding van Marcio Souza
Fundação Dom Cabral | Masters Business Admin |
University of Sao Paulo | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 4 |
---|---|
PTC THERAPEUTICS, INC. | Health Technology |
SPYRE THERAPEUTICS, INC. | Health Technology |
CLEARPOINT NEURO, INC. | Health Technology |
PRAXIS PRECISION MEDICINES, INC. | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
NPS Pharmaceuticals, Inc.
NPS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology NPS Pharmaceuticals, Inc. developed drugs for bone and mineral disorders. It also developed Natpara for the treatment of adult hypoparathyroidism. The company was founded by Hunter Jackson and Thomas N. Parks on October 22, 1986 and is headquartered in Bedminster, NJ. | Health Technology |